Anthony Sun's most recent trade in Cognex Corp. was a trade of 6,973 Restricted Stock Unit done . Disclosure was reported to the exchange on Feb. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 6,973 | 0 | - | - | Restricted Stock Unit | |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 6,973 | 319,967 (0%) | 0% | 0 | Common Stock | |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 2,134 | 0 | - | - | Restricted Stock Unit | |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 2,134 | 323,848 (0%) | 0% | 0 | Common Stock | |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 1,747 | 2,913 | - | - | Restricted Stock Unit | |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 1,747 | 321,714 (0%) | 0% | 0 | Common Stock | |
| Cognex Corp. | Anthony Sun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 8,324 | 8,324 | - | - | Restricted Stock Unit | |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.62 per share. | 22 Nov 2024 | 26,000 | 52,608 (0%) | 0% | 20.6 | 536,250 | Common Stock |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 26,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Sale of securities on an exchange or to another person at price $ 40.03 per share. | 22 Nov 2024 | 26,000 | 26,608 (0%) | 0% | 40.0 | 1,040,671 | Common Stock |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2024 | 1,281 | 312,994 (0%) | 0% | 0 | Common Stock | |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2024 | 1,281 | 2,134 | - | - | Restricted Stock Unit | |
| Cognex Corp. | Anthony Sun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 6,973 | 6,973 | - | - | Restricted Stock Unit | |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 1,166 | 311,713 (0%) | 0% | 0 | Common Stock | |
| Cognex Corp. | Sun Anthony | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 1,166 | 4,660 | - | - | Restricted Stock Unit | |
| Cognex Corp. | Sun Anthony | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 1,519 | 0 | - | - | Restricted Stock Unit | |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 1,519 | 310,547 (0%) | 0% | 0 | Common Stock | |
| Cognex Corp. | Sun Anthony | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.66 per share. | 09 Jan 2024 | 26,000 | 26,608 (0%) | 0% | 19.7 | 511,030 | Common Stock |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 26,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 5,826 | 5,826 | - | - | Restricted Stock Unit | |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 854 | 3,415 | - | - | Restricted Stock Unit | |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 854 | 309,636 (0%) | 0% | 0 | Common Stock | |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 912 | 1,519 | - | - | Restricted Stock Unit | |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 912 | 308,782 (0%) | 0% | 0 | Common Stock | |
| Cognex Corp. | Anthony Sun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 608 | 608 (0%) | 0% | 0 | Common Stock | |
| Cognex Corp. | Anthony Sun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 608 | 307,262 (0%) | 0% | 0 | Common Stock | |
| Cognex Corp. | Anthony Sun | Director | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 30 Nov 2022 | 30,000 | 0 (0%) | 0% | 50.0 | 1,500,441 | Common Stock |
| Cognex Corp. | Anthony Sun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2022 | 30,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2022 | 30,000 | 30,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2022 | 30,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.53 per share. | 30 Nov 2022 | 30,000 | 30,000 (0%) | 0% | 10.5 | 315,825 | Common Stock |
| Cognex Corp. | Anthony Sun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2022 | 26,000 | 26,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2022 | 26,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2022 | 26,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2022 | 26,000 | 26,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2022 | 26,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2022 | 26,000 | 26,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2022 | 26,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2022 | 26,000 | 26,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2022 | 26,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2022 | 26,000 | 26,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2022 | 23,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2022 | 23,000 | 23,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2022 | 13,000 | 13,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2022 | 13,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 48.50 per share. | 04 Apr 2022 | 10,471 | 1,186,060 | - | 48.5 | 507,844 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 51.34 per share. | 04 Apr 2022 | 7,971 | 1,178,089 | - | 51.3 | 409,201 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 52.11 per share. | 04 Apr 2022 | 2,500 | 1,175,589 | - | 52.1 | 130,273 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 50.11 per share. | 01 Mar 2022 | 9,771 | 1,197,231 | - | 50.1 | 489,626 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 49.74 per share. | 01 Mar 2022 | 8,771 | 1,208,702 | - | 49.7 | 436,298 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 50.05 per share. | 01 Mar 2022 | 1,700 | 1,207,002 | - | 50.1 | 85,086 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 50.91 per share. | 01 Mar 2022 | 700 | 1,196,531 | - | 50.9 | 35,640 | Common Stock |
| Cognex Corp. | Anthony Sun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 4,269 | 4,269 | - | - | Restricted Stock Unit | |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2022 | 608 | 2,431 | - | - | Restricted Stock Unit | |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2022 | 608 | 307,870 (0%) | 0% | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 118,319 | 118,319 | - | - | Stock Option (Right to Buy) | |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 50,431 | 1,222,206 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 50.16 per share. | 10 Feb 2022 | 4,208 | 1,217,998 | - | 50.2 | 211,091 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 50.75 per share. | 10 Feb 2022 | 525 | 1,217,473 | - | 50.7 | 26,642 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 57.87 per share. | 01 Feb 2022 | 8,128 | 1,174,118 | - | 57.9 | 470,387 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 56.81 per share. | 01 Feb 2022 | 4,124 | 1,188,593 | - | 56.8 | 234,283 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 57.63 per share. | 01 Feb 2022 | 3,419 | 1,185,174 | - | 57.6 | 197,028 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 58.59 per share. | 01 Feb 2022 | 2,828 | 1,182,346 | - | 58.6 | 165,685 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 58.29 per share. | 01 Feb 2022 | 2,343 | 1,171,775 | - | 58.3 | 136,579 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 59.31 per share. | 01 Feb 2022 | 100 | 1,182,246 | - | 59.3 | 5,931 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jan 2022 | 15,000 | 1,213,659 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 78.76 per share. | 03 Jan 2022 | 6,871 | 1,194,317 | - | 78.8 | 541,140 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 80.36 per share. | 03 Jan 2022 | 4,372 | 1,205,589 | - | 80.4 | 351,319 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 78.26 per share. | 03 Jan 2022 | 2,573 | 1,211,086 | - | 78.3 | 201,362 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 77.71 per share. | 03 Jan 2022 | 2,000 | 1,201,188 | - | 77.7 | 155,425 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 79.54 per share. | 03 Jan 2022 | 1,556 | 1,192,761 | - | 79.5 | 123,767 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 79.18 per share. | 03 Jan 2022 | 1,125 | 1,209,961 | - | 79.2 | 89,083 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 81.14 per share. | 03 Jan 2022 | 1,108 | 1,204,481 | - | 81.1 | 89,902 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 82.18 per share. | 03 Jan 2022 | 993 | 1,203,488 | - | 82.2 | 81,604 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 83.89 per share. | 03 Jan 2022 | 300 | 1,203,188 | - | 83.9 | 25,168 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 80.43 per share. | 03 Jan 2022 | 44 | 1,192,717 | - | 80.4 | 3,539 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Dec 2021 | 125,000 | 103,650 | - | 0 | Common Stock | |
| Hyperion DeFi Inc. | Anthony Y. Sun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 9,653 | 9,653 | - | - | Stock Option (right to buy) | |
| Hyperion DeFi Inc. | Anthony Y. Sun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 6,963 | 26,322 (0%) | 0% | 0 | Common Stock, par value $.0001 | |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 80.32 per share. | 01 Nov 2021 | 5,180 | 1,253,398 | - | 80.3 | 416,050 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 80.72 per share. | 01 Nov 2021 | 4,420 | 1,266,123 | - | 80.7 | 356,796 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 81.10 per share. | 01 Nov 2021 | 3,797 | 1,249,601 | - | 81.1 | 307,928 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 81.48 per share. | 01 Nov 2021 | 3,251 | 1,262,872 | - | 81.5 | 264,877 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 82.49 per share. | 01 Nov 2021 | 2,600 | 1,260,272 | - | 82.5 | 214,462 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 79.40 per share. | 01 Nov 2021 | 1,494 | 1,258,578 | - | 79.4 | 118,624 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 83.18 per share. | 01 Nov 2021 | 200 | 1,260,072 | - | 83.2 | 16,637 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 66.58 per share. | 04 Oct 2021 | 16,308 | 1,270,570 | - | 66.6 | 1,085,757 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 65.95 per share. | 04 Oct 2021 | 10,464 | 1,286,878 | - | 66.0 | 690,136 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 67.15 per share. | 04 Oct 2021 | 27 | 1,270,543 | - | 67.1 | 1,813 | Common Stock |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2021 | 30,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cognex Corp. | Anthony Sun | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.40 per share. | 08 Sep 2021 | 30,000 | 337,262 (0%) | 0% | 8.4 | 251,925 | Common Stock |
| Cognex Corp. | Anthony Sun | Director | Sale of securities on an exchange or to another person at price $ 86.41 per share. | 08 Sep 2021 | 30,000 | 307,262 (0%) | 0% | 86.4 | 2,592,300 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 67.82 per share. | 01 Sep 2021 | 13,482 | 1,298,167 | - | 67.8 | 914,330 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 67.09 per share. | 01 Sep 2021 | 12,487 | 1,311,649 | - | 67.1 | 837,805 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 68.58 per share. | 01 Sep 2021 | 825 | 1,297,342 | - | 68.6 | 56,581 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 51.30 per share. | 02 Aug 2021 | 9,182 | 1,334,848 | - | 51.3 | 471,023 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 02 Aug 2021 | 6,900 | 1,344,030 | - | 50.0 | 345,072 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 50.70 per share. | 02 Aug 2021 | 4,659 | 1,324,743 | - | 50.7 | 236,230 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 02 Aug 2021 | 2,513 | 1,329,402 | - | 50.0 | 125,686 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 52.29 per share. | 02 Aug 2021 | 2,006 | 1,332,842 | - | 52.3 | 104,888 | Common Stock |
| Zentalis Pharmaceuticals Inc | Anthony Y. Sun | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 53.14 per share. | 02 Aug 2021 | 927 | 1,331,915 | - | 53.1 | 49,265 | Common Stock |